NewcelX raises $1.35 million in equity financing at 30% premium
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/9/2026
- Hut 8 Mining Corp. (HUT) PT Raised to $55 at KBW As Management Delivers
- UK's Ofcom requires tech firms to create crisis response plans
- Exclusive-SpaceX plans to set IPO price at $135 per share, targeting record $75 billion raise, source says
- Salesforce to acquire metering platform M3TER for consumption billing
- Micron to deliver 'another strong quarter', Goldman says
NewcelX Announces Pricing of $1.35 Million Equity Financing at 30% Premium Pricing
April 1, 2026 7:21 AM EDTFinancing reflects strong investor confidence and supports advancement of lead Type 1 Diabetes program
ZURICH, Switzerland, April 01, 2026 (GLOBE NEWSWIRE) -- NewcelX Ltd. (Nasdaq: NCEL), a clinical-stage biopharmaceutical company developing stem cell-based therapies for Type 1 Diabetes, today announced that it has entered into securities purchase agreements for a private placement at a purchase price of $2.75 per share, representing a 30% premium to the last closing price of the Companys common shares on March 31, 2026.
Pursuant to the terms of the securities purchase agreements, the Company is selling an... More
